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PQUARTERLY FOCUS ISSUE: HEART FAILURE Right Ventricular Cardiomyopathy
Prevalence and Pathophysiologic Attributes
of Ventricular Dyssynchrony in Arrhythmogenic
Right Ventricular Dysplasia/Cardiomyopathy
Laurens F. Tops, MD,*‡ Kalpana Prakasa, MD,* Harikrishna Tandri, MD,* Darshan Dalal, MD,*
Rahul Jain, MD,* Veronica L. Dimaano, MD,* David Dombroski, MD,† Cynthia James, PHD,*
Crystal Tichnell, MGC,* Amy Daly, MSC,* Frank Marcus, MD,§ Martin J. Schalij, MD,‡
Jeroen J. Bax, MD,‡ David Bluemke, MD,† Hugh Calkins, MD,* Theodore P. Abraham, MD*
Baltimore, Maryland; Leiden, the Netherlands; and Tucson, Arizona
Objectives This study sought to investigate the prevalence and mechanisms underlying right ventricular (RV) dyssynchrony in
arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) using tissue Doppler echocardiography (TDE).
Background An ARVD/C is characterized by fibrofatty replacement of RV myocardium and RV dilation. These pathologic
changes may result in electromechanical dyssynchrony.
Methods Echocardiography, both conventional and TDE, was performed in 52 ARVD/C patients fulfilling Task Force crite-
ria and 25 control subjects. The RV end-diastolic and -systolic areas, right ventricular fractional area change (RV-
FAC), and left ventricular (LV) volumes and function were assessed. Mechanical synchrony was assessed by
measuring differences in time-to-peak systolic velocity (TSV) between the RV free wall, ventricular septum, and
LV lateral wall. An RV dyssynchrony was defined as the difference in TSV between the RV free wall and the ven-
tricular septum, 2 SD above the mean value for control subjects.
Results The mean difference in RV TSV was higher in ARVD/C compared with control subjects (55  34 ms vs. 26  15
ms, p  0.001). Significant RV dyssynchrony was not noted in any of the control subjects. Based on a cutoff
value of 56 ms, significant RV dyssynchrony was present in 26 ARVD/C patients (50%). Patients with RV dyssyn-
chrony had a larger RV end-diastolic area (22  5 cm2 vs. 19  4 cm2, p  0.02), and lower RVFAC (29  8%
vs. 34  8%, p  0.03) compared with ARVD/C patients without RV dyssynchrony. No differences in QRS dura-
tion, LV volumes, or function were present between the 2 groups.
Conclusions An RV dyssynchrony may occur in up to 50% of ARVD/C patients, and is associated with RV remodeling. This
finding may have therapeutic and prognostic implications in ARVD/C. (J Am Coll Cardiol 2009;54:445–51)
© 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.04.038c
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errhythmogenic right ventricular dysplasia cardiomyopathy
ARVD/C) is an inherited disease characterized by fibro-
atty replacement of right ventricular (RV) myocardium (1).
he diagnosis is established based on the presence of a
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ccepted April 14, 2009.onglomeration of factors (2,3). Other than ventricular
rrhythmias, ARVD/C results in progressive RV dilation
nd systolic dysfunction leading to heart failure (4,5).
Ventricular electromechanical delay (or mechanical dys-
ynchrony) has been well described in left ventricular (LV)
ailure and has formed the basis of cardiac resynchronization
herapy leading to significant improvements in symptoms,
unctional capacity, and survival in heart failure patients (6).
lthough RV mechanical dyssynchrony has been described
n pulmonary hypertension (7), there are no data on whether
primary RV cardiomyopathy such as ARVD/C is associ-
ted with mechanical dyssynchrony. Tissue Doppler echo-
ardiography (TDE) and strain echocardiography (SE) have
merged as the predominant means of evaluating ventricular
echanics (8,9).
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RV Dyssynchrony in ARVD/C July 28, 2009:445–51Several components of the
ARVD/C disease process could
potentially lead to the develop-
ment of RV mechanical dyssyn-
chrony. Fibrofatty infiltration
could involve the RV conduction
system, resulting in electrical and
electromechanical delays. Similar
to LV failure, RV dilation and
dysfunction may cause dyssyn-
chrony. Lastly, other factors such
as pulmonary pressures and LV
involvement may influence RV
mechanical properties. Impor-
tantly, ventricular electrome-
chanical dyssynchrony has prog-
nostic and therapeutic implications
(10,11).
Accordingly, the aims of this
study were to determine the
prevalence of mechanical dyssyn-
chrony in a large cohort of
ARVD/C patients and to better
elucidate the factors influencing
V mechanics in ARVD/C.
ethods
tudy population and protocol. This study was approved
y the institutional review board with written informed
onsent obtained in all subjects. The study population
omprised 52 ARVD/C patients with diagnosis confirmed
y Task Force criteria (2) and 25 control subjects. All
ontrol subjects were healthy volunteers, recruited on cam-
us, with no history of medical illness, not on any cardio-
ctive medications, and who had a normal echo Doppler
xamination result (18 men, 7 women; mean age 32  6
ears). All patients underwent a detailed history and phys-
cal examination, 12-lead electrocardiogram (ECG), signal-
veraged ECG, conventional echocardiography, and
DE/SE.
chocardiography. Conventional and TDE/SE images
ere acquired from at least 3 consecutive heart beats and
igitally stored for off-line analysis using a Vivid 7 ultra-
ound machine (GE Healthcare, Waukesha, Wisconsin).
ffline analysis was performed using EchoPAC PC version
.1 (GE Healthcare). During image acquisition, special care
as taken to acquire accurate images of the RV free wall.
ff-plane images of the RV were acquired to maximize
isualization of RV morphology.
The RV outflow tract dimension was measured in the
arasternal short-axis view at the level of the aortic valve
lane (12). In addition, right ventricular end-diastolic area
RVEDA) and right ventricular end-systolic area (RVESA)
ere measured by tracing the RV endocardial border on the
Abbreviations
and Acronyms
ARVD/C  arrhythmogenic
right ventricular
dysplasia/cardiomyopathy
CI  confidence interval
ECG  electrocardiogram
LV  left
ventricle/ventricular
RV  right
ventricle/ventricular
RVEDA  right ventricular
end-diastolic area
RVESA  right ventricular
end-systolic area
RVFAC  right ventricular
fractional area change
SE  strain
echocardiography
TDE  tissue Doppler
echocardiography
Tsv  time-to-peak systolic
velocitypical 4-chamber view and right ventricular fractional area shange (RVFAC) was calculated as a measure of RV systolic
unction using the following equation: RVFAC 
RVEDA  RVESA)/RVEDA  100% (12). Biplane LV
nd-diastolic and -systolic volumes were assessed from the
pical 2- and 4-chamber images, and LV ejection fraction was
alculated using the biplane Simpson formula (13).
DE/SE. Standard apical 4-chamber images and narrow-
ngle-sector images were acquired for tissue Doppler and
train analysis. Adjustments to the sector width were made
o visualize 1 myocardial wall at a time (RV free wall,
nterventricular septum, LV lateral wall), to obtain an
ptimal alignment between the wall and the ultrasound
eam, and to maximize frame rates (mean frame rate 253 
6 frames/s). The gain settings, filters, and pulse repetition
requency were adjusted to optimize color saturation and to
void aliasing.
Off-line analysis was performed by placing the Doppler
ample at the basal segment of the RV free wall, interven-
ricular septum, and LV lateral wall, as previously described
14). Semiautomated tissue tracking was used to maintain
he sample area within the region of interest throughout the
ardiac cycle. Peak systolic tissue velocity of each segment
as obtained and averaged from 3 cardiac cycles. For peak
ystolic strain analysis, an offset (strain) distance of 12 mm
as used; for all segments the time-to-peak systolic strain
as similarly assessed. Off-line analyses were performed by
observers, blinded to the results of the echocardiographic
V function analysis.
entricular dyssynchrony. For the assessment of ventric-
lar dyssynchrony, the time from the onset of the QRS
omplex to the peak systolic tissue velocity of different
egments was measured (TSV). The difference between the
SV of the septum and the TSV of the RV free wall was
alculated as an indicator of RV dyssynchrony. Significant
V dyssynchrony was defined as a septal to RV free wall
SV delay exceeding 2 SD above the mean value for the
ontrol group.
Similarly, for LV dyssynchrony the difference in TSV
etween the septum and the LV lateral wall was calculated.
value 2 SD above the mean value derived from the
ontrol group was used as a cutoff value for the presence of
ignificant LV dyssynchrony. Finally, interventricular dys-
ynchrony was calculated as the difference in TSV between
he RV free wall and the LV lateral wall. The cutoff value
or significant interventricular dyssynchrony was defined
imilar to RV and LV dyssynchrony.
tatistical analysis. Continuous data are presented as
ean  SD; categorical data are presented as frequencies
nd percentages. Differences between the ARVD/C pa-
ients and the control subjects, and between the ARVD/C
atients with and without ventricular dyssynchrony, were
valuated using an unpaired Student t test (continuous
ariables) or chi-square tests (dichotomous variables). Dif-
erences in continuous variables between control subjects
nd ARVD/C patients with and without ventricular dys-
ynchrony were evaluated with 1-way analysis of variance.
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July 28, 2009:445–51 RV Dyssynchrony in ARVD/Correlations between echocardiographic variables and the
xtent of RV dyssynchrony were assessed with a Pearson
orrelation test.
Interobserver and intraobserver variability for the assess-
ent of TSV of the RV free wall and the interventricular
eptum and RV dyssynchrony were assessed using Bland-
ltman analysis, in 10 random ARVD/C patients that were
nalyzed by 2 independent observers (interobserver variabil-
ty) and by a single observer at 2 different time points
intraobserver variability); mean differences  SD and 95%
onfidence intervals (CIs) are reported. In addition, the
appa statistic was used to assess the interobserver and
ntraobserver variability for the classification of the presence
r absence of RV dyssynchrony.
All statistical analyses were performed using SPSS soft-
are (version 12.0, SPSS Inc., Chicago, Illinois). All
tatistical tests were 2-sided, and a p value 0.05 was
onsidered statistically significant.
esults
aseline characteristics of the 52 ARVD/C patients are
ummarized in Table 1. In none of the patients, symptoms
f right-sided heart failure were present. Right ventricular
reas (RVEDA and RVESA) were higher and RVFAC was
ignificantly lower in ARVD/C compared with the control
ubjects (Table 2). There were no significant intergroup
ifferences in LV volumes and function. Peak systolic
elocities and strain values in the interventricular septum
nd the LV lateral wall were comparable between the
RVD/C patients and control subjects (Table 2). In con-
rast, RV free wall peak systolic velocity (7.4  2.1 cm/s vs.
.9  1.2 cm/s, p  0.001) and RV free wall peak systolic
train (19  7% vs. 25  9%, p  0.002) were
ignificantly lower in ARVD/C patients compared with
ontrol subjects, respectively.
entricular dyssynchrony. In all subjects, echocardio-
raphic images were of sufficient quality to assess TSV. The
ean TSV of the septum and the RV free wall in the
aseline CharacteristicsTable 1 Baseline Characteristics
ARVD/C Patients (n  52)
Age, yrs 41  12
Sex, male/female 22/30
Symptomatic, n (%) 45 (87)
Syncope, n (%) 13 (25)
Palpitations, n (%) 18 (35)
Ventricular tachycardia, n (%) 14 (27)
Other symptoms, n (%) 9 (17)
Implantable cardioverter-defibrillator, n (%) 45 (87)
Filtered QRS duration, ms 131  36
Right bundle branch block, n (%) 10 (19)
Epsilon waves, n (%) 0 (0)
T-wave inversion in right pre-cordial leads, n (%) 39 (75)
RV systolic pressure, mm Hg 29  6uRVD/C  arrhythmogenic right ventricular dysplasia/cardiomyopathy; RV  right ventricular.RVD/C patients was 159  40 ms and 210  42 ms,
espectively. In the control subjects, the mean TSV of the
eptum and the RV free wall was 135  39 ms and 160 
3 ms, respectively. Mean time-to-peak strain of the septum
nd RV free wall was 387  67 ms and 434  73 ms in the
RVD/C patients and 345  88 ms and 368  75 ms in
he control subjects.
The mean difference in TSV between the septum and the
V free wall, representing RV dyssynchrony, was 55  34
s in the ARVD/C patients and 26  15 ms in the control
ubjects (p  0.001). Based on a cutoff value of 56 ms,
ignificant RV dyssynchrony was present in 26 ARVD/C
atients (50%). In these patients, the mean RV dyssyn-
hrony was 84  20 ms, whereas it was 26  16 ms in the
emaining patients (p  0.001). An example of a patient
ith significant RV dyssynchrony is shown in Figure 1.
The mean TSV for the LV lateral wall in the ARVD/C
atients and the control subjects was 171 47 ms and 155
7 ms, respectively. Mean time-to-peak strain of the LV lateral
all was 398 70 ms in the ARVD/C patients and 370 86
s in the control subjects. There was no significant difference
n LV dyssynchrony between the ARVD/C patients and the
ontrol subjects (21 18 ms vs. 22 19 ms, p 0.7). Using
cutoff value of 60 ms (2 SD of the control subjects), 2
RVD/C patients (4%) showed significant LV dyssynchrony.
Interventricular dyssynchrony, calculated as the difference
n TSV between the RV free wall and the LV lateral wall,
as 53  36 ms in the ARVD/C patients and 21  15 ms
n the control subjects (p  0.001). Based on a cutoff value
f 51 ms (2 SD of the control subjects), significant
nterventricular dyssynchrony was present in 22 patients
42%) with ARVD/C. In these patients, mean interventric-
chocardiographic DataTable 2 Echocardiographic Data
Variable
Control Subjects
(n  25)
ARVD/C Patients
(n  52) p Value
RVOT diameter (cm) 2.6 0.2 2.9 0.4 0.001
RVEDA (cm2) 17 3 20 5 0.001
RVESA (cm2) 9 2 14 4 0.001
RVFAC (%) 44 7 32 8 0.001
LVEDV (ml) 108 31 104 27 0.5
LVESV (ml) 45 14 45 14 0.9
LVEF (%) 59 5 57 5 0.1
Septum
Peak systolic velocity (cm/s) 5.9 1.1 5.4 1.1 0.1
Peak systolic strain (%) 24 6 21 7 0.1
RV free wall
Peak systolic velocity (cm/s) 9.9 1.2 7.4 2.1 0.001
Peak systolic strain (%) 25 9 19 7 0.002
LV lateral wall
Peak systolic velocity (cm/s) 7.0 2.1 6.5 1.4 0.2
Peak systolic strain (%) 18 8 18 6 0.2
V left ventricular; LVEDV left ventricular end-diastolic volume; LVEF left ventricular ejection
raction; LVESA  left ventricular end-systolic area; LVESV  left ventricular end-systolic volume;
VEDA  right ventricular end-diastolic area; RVESA  right ventricular end-systolic area;
VFAC  right ventricular fractional area change; RVOT  right ventricular outflow tract; other
bbreviations as in Table 1.lar dyssynchrony was 88  17 ms, whereas it was 27  21
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RV Dyssynchrony in ARVD/C July 28, 2009:445–51s in the remaining patients (p  0.001). In 19 of the 26
atients with RV dyssynchrony (73%), significant interven-
ricular dyssynchrony was present. Conversely, in 23 of the
6 patients without RV dyssynchrony (88%), no significant
nterventricular dyssynchrony was present.
actors influencing RV dyssynchrony. We examined sev-
ral morphologic and functional factors that could poten-
ially impact RV mechanical synchrony. These included:
) electrocardiographic: the presence of RV conduction
bnormalities as typified by QRS duration and presence of
ight bundle branch block; 2) morphologic: RV volumes and
V volumes; and 3) functional: RV function and LV
unction. To study these factors, ARVD/C patients were
ivided into those with RV dyssynchrony (n  26) and
hose without RV dyssynchrony (n  26).
No differences in RV conduction abnormalities, evaluated
y signal-averaged and surface ECG, were noted between
he 2 groups: filtered QRS duration on signal averaged
CG was similar in ARVD/C patients with versus those
ithout RV dyssynchrony (134  41 ms vs. 128  32 ms,
espectively; p  0.6). No difference in the prevalence of
-wave inversion in right precordial leads was noted be-
ween the 2 groups (with RV dyssynchrony n 18, without
V dyssynchrony n 21, p 0.5). Similarly, there were no
ifferences in the prevalence of right bundle branch block
oted in 5 patients (19%) with RV dyssynchrony and in 5
atients (19%) without RV dyssynchrony (p  1.0). In
Figure 1 Example of an ARVD/C Patient With Significant RV D
Samples are placed at the basal parts of the septum (yellow curve), right ventricu
patient, a significant delay between the septum and the RV free wall was present
tricular dysplasia/cardiomyopathy; AVC  aortic valve closure; AVO  aortic valveddition, there was no difference in the number of patients Aith documented ventricular tachycardia at baseline be-
ween the group with and the group without RV dyssyn-
hrony (10 patients vs. 4 patients, p  0.1).
Compared with patients without RV dyssynchrony, the
atients with RV dyssynchrony had a larger RVEDA
Table 3), and a lower RVFAC (Fig. 2). No significant
chrony
V) free wall (red curve), and left ventricular (LV) lateral wall (green curve). In this
s), indicated by the yellow and red arrows. ARVD/C  arrhythmogenic right ven-
g.
chocardiographic Data in ARVD/Catients With and Without RV yssynchronyTable 3 Echo ardiographic ata in ARVD/CPatients With and Without RV Dyssynchrony
Variable
Without RV
Dyssynchrony
(n  26)
With RV
Dyssynchrony
(n  26) p Value
RVOT diameter (cm) 2.9 0.4 2.9 0.4 0.9
RVEDA (cm2) 19 4 22 5 0.02
RVESA (cm2) 12 3 16 5 0.005
RVFAC (%) 34 8 29 8 0.03
LVEDV (ml) 104 28 103 26 1.0
LVESV (ml) 45 13 45 15 1.0
LVEF (%) 57 4 57 6 0.8
Septum
Peak systolic velocity (cm/s) 5.4 1.3 5.4 1.0 1.0
Peak systolic strain (%) 21 7 22 7 0.8
RV free wall
Peak systolic velocity (cm/s) 7.4 2.5 7.3 1.7 0.9
Peak systolic strain (%) 22 7 16 6 0.001
LV lateral wall
Peak systolic velocity (cm/s) 6.4 1.5 6.6 1.4 0.5
Peak systolic strain (%) 19 7 16 5 0.1yssyn
lar (R
(110 m
openinbbreviations as in Tables 1 and 2.
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July 28, 2009:445–51 RV Dyssynchrony in ARVD/Cifferences in LV volumes, function, and peak systolic
elocities and peak systolic strain were noted between
atients with and without RV dyssynchrony. In contrast,
eak systolic strain of the RV free wall was significantly
ecreased in patients with RV dyssynchrony compared with
atients without RV dyssynchrony (Fig. 2).
A modest but significant correlation was found between RV-
AC and RV dyssynchrony (r0.38, p 0.001) and between
VEDA and RV dyssynchrony (r  0.38, p  0.001). In
ddition, a modest but significant correlation was found between
eak systolic strain of the RV free wall and RV dyssynchrony (r
.40, p  0.001).
eproducibility of RV dyssynchrony. The intraobserver
nd interobserver variability for TSV for the RV free wall
ere 1.0  16.6 ms (95% CI: 31.6 to 33.6), and 0  26.7
s (95% CI:52.3 to 52.3), respectively. The intraobserver
nd interobserver variability for RV dyssynchrony were 0 
8.9 ms (95% CI:36.9 to 36.9) and5.0 29.5 ms (95%
I: 62.9 to 52.9), respectively. For the classification of
Figure 2 RVFAC and RV Peak Systolic Strain
in Control Subjects and ARVD/C Patients
Right ventricular fractional area change (RVFAC) (upper panel) and RV peak
systolic strain (lower panel) in the 25 control subjects, 26 ARVD/C patients
without RV dyssynchrony (DYSS), and 26 ARVD/C patients with RV DYSS. Both
RVFAC and RV peak systolic strain were significantly decreased in the ARVD/C
patients with RV DYSS. Abbreviations as in Figure 1.he presence or absence of RV dyssynchrony, an excellent bgreement was noted between the 2 observers (  0.80)
nd within the same observer (  1.0).
iscussion
e presented a previously unreported finding of significant
entricular mechanical dyssynchrony in patients with a
rimary RV cardiomyopathy, ARVD/C. In a relatively large
ohort of ARVD/C patients, we have shown RV dyssyn-
hrony in 50% and interventricular dyssynchrony in 42% of
he patients. Patients with RV dyssynchrony had larger RV
olumes and lower RV function compared with control
ubjects.
V dyssynchrony. The presence of LV and interventricu-
ar dyssynchrony has been studied in a broad spectrum of
linical settings (9). In contrast, RV dyssynchrony has not
een studied extensively. The presence of RV dyssynchrony
as first reported by Lopez-Candales et al. (7) in 20 patients
ith pulmonary hypertension. Using time-to-peak strain
etween the septum and RV free wall, RV dyssynchrony
as found to be more pronounced in patients with pulmo-
ary hypertension as compared with control subjects (92 
8 ms vs. 11  23 ms, p  0.001). In contrast, there were
o differences in LV dyssynchrony between the 2 groups
7). Similarly, intraobserver and interventricular dyssyn-
hrony was examined in 34 patients with LV systolic heart
ailure, mean LV ejection fraction 22  7% (56% with
onischemic cardiomyopathy) (15). The mean RV dyssyn-
hrony was 59  45 ms, and the mean LV dyssynchrony
as 80  62 ms.
In a larger unselected cohort of patients with a primary
V cardiomyopathy (ARVD/C), we report for the first time
he occurrence of significant RV and interventricular me-
hanical dyssynchrony. As opposed to previous studies,
yssynchrony in this population occurred in the absence of
onfounding factors such as pulmonary hypertension and
V failure. Our data also established a cutoff value for
echanical dyssynchrony in the RV using 25 healthy
ontrol subjects. Interestingly, our cutoff value of 56 ms is
lose to the previously reported cutoff values for LV dys-
ynchrony (16).
actors influencing RV dyssynchrony in ARVD/C. The
resence of RV dyssynchrony is not surprising given previ-
us and recent knowledge about the pathophysiology of
RVD/C. Recent data on potential causal genes suggest
hat most mutations involve genes that encode desmosomal
roteins and include but are not limited to desmoplakin,
lakophilin 2, and desmoglein (17–19). Thus ARVD/C is
onsidered a desmopathy that is likely associated with
bnormal cell-to-cell coupling, both electrically and me-
hanically, providing the substrate for the RV dyssynchrony.
Akin to LV dysfunction, electrical conduction abnormal-
ties in the RV could be associated with mechanical delays.
owever, in our cohort we found no differences in QRS
uration and/or the presence of right bundle branch block
etween patients with and without RV dyssynchrony. Al-
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RV Dyssynchrony in ARVD/C July 28, 2009:445–51hough in general the presence of mechanical dyssynchrony
s related to intraventricular conduction abnormalities, sub-
tantial LV ventricular dyssynchrony has been previously
hown in the absence of QRS prolongation (20,21). Thus
RVD/C may be another example of dyssynchrony with a
arrow QRS. Another potential explanation is that ventric-
lar dyssynchrony in ARVD/C is related to regional abnor-
alities and heterogeneities in conduction and contractility,
ot evident on a surface ECG (22).
In contrast to the lack of association between electrocar-
iographic abnormalities and dyssynchrony, RV morphol-
gy and function seemed to be related to RV dyssynchrony.
arger RVEDA and RVESA were noted in the patients
ith RV dyssynchrony. However, this relationship was not
s strong as previously reported in patients with pulmonary
ypertension (r  0.70, p  0.001 between RVEDA and
V dyssynchrony) (23). One potential reason for a weaker
elationship could be the difference in pathology. An
RVD/C is a patchy infiltrative process with regional
ilation, whereas pulmonary hypertension (pressure over-
oad) affects the RV globally and is more likely to cause
niform chamber dilation in the load-sensitive RV (24).
Similar to dyssynchrony associated with LV failure
20,25), our data indicate a relationship between RV func-
ion, as determined by RVFAC and RV peak systolic strain,
nd RV dyssynchrony in ARVD/C. These findings are also
n line with previous studies in patients with pulmonary
ypertension (7,23) and systolic heart failure (15). Finally,
brofatty infiltration in ARVD/C could involve the con-
uction system and thereby introduce electromechanical
elays resulting in dyssynchrony. Similar relationships have
een examined in ischemic cardiomyopathy, in which sig-
ificant amounts of fibrosis result in the presence of me-
hanical dyssynchrony (22).
Our findings present several incremental points of knowl-
dge concerning ARVD/C that could be potentially used
or prognostic and therapeutic purposes. In patients with
V failure, the presence of significant ventricular dyssyn-
hrony is associated with a worse prognosis (10). Dyssyn-
hrony in ARVD/C may similarly predict worse clinical
utcomes. Serial monitoring of RV dyssynchrony may
dentify patients at higher risk and deserving of aggressive
herapy. Cardiac resynchronization therapy has improved
ymptoms and survival in dyssynchronous left heart failure
8,26). The presence of significant RV or interventricular
yssynchrony may introduce the possibility of resynchroni-
ation therapy for right-sided failure in patients with
RVD/C who would otherwise be transplantation candi-
ates. However, more prospective studies are needed to
urther elucidate the clinical implications of the presence of
V dyssynchrony in ARVD/C.
tudy limitations. The mean age of the control group
as lower than the ARVD/C patients. This may affect
he definition of RV dyssynchrony for the ARVD/C
atients. However, it has been shown that ventricular
yssynchrony does not depend on age (27). In addition, iV dyssynchrony was comparable between the control
ubjects and the ARVD/C patients in the present study.
astly, we strictly selected healthy normal control sub-
ects because a previous definition for RV dyssynchrony
as not available. Older control subjects tended to have
edical conditions such as hypertension and diabetes,
hich have effects on RV dyssynchrony that are unclear
nd were therefore excluded from the normal group.
arger studies with the power to assess the influence of
ther comorbidities should ideally include an age-
atched control group.
Furthermore, in the present study only TDE was used to
efine interventricular dyssynchrony. Interventricular dys-
ynchrony calculated as the time difference between RV and
V pre-ejection intervals may have also provided addi-
ional information. However, RV outflow Doppler stud-
es were not consistently performed in a fair number of
ubjects, and we are unable to assess this parameter in our
opulation.
Duration of disease is likely an important factor in the
evelopment of RV dyssynchrony in ARVD/C. However,
etermining the onset and duration of disease in this
elatively asymptomatic group is challenging. We are there-
ore unable to evaluate its influence on RV dyssynchrony.
Similarly, the extent of fibrofatty infiltration may be an
mportant factor in the pathogenesis of RV dyssynchrony in
RVD/C patients. In a small subset of patients enrolled in
he present study, who also had clinical magnetic resonance
maging, we found no correlation between the extent of
brofatty infiltration (as assessed by gadolinium enhance-
ent) and RV dyssynchrony. These data were not presented
ecause of the small sample size and lack of statistical power
o offer reliable conclusions.
Finally, although the present study is the first observa-
ional study that shows the presence of RV dyssynchrony in
RVD/C patients, unfortunately, this cross-sectional anal-
sis does not provide insights into the clinical significance of
he presence of RV dyssynchrony, and its exact role in
RVD/C management remains unclear. However, our
ndings prompt larger longitudinal studies to evaluate the
nfluence of dyssynchrony on diagnosis, treatment, and prog-
ostication of ARVD/C patients, including prediction of
linical outcomes such as heart failure, potential for arrhyth-
ias, and response to treatment. In particular, future studies
ay allow a more systematic assessment of several important
actors including but not limited to duration of disease and
enotype.
onclusions
ignificant RV dyssynchrony may occur in up to 50% of
RVD/C patients and is associated with RV remodeling
nd dysfunction rather than electrocardiographic abnormal-
ties. This finding may have therapeutic and prognostic
mplications in ARVD/C.
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